| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 111.15B | 109.03B | 93.25B | 87.53B | 84.05B | 78.73B |
| Gross Profit | 41.55B | 40.38B | 30.61B | 27.21B | 28.23B | 25.66B |
| EBITDA | 25.41B | 26.02B | 16.66B | 13.12B | 15.98B | 17.80B |
| Net Income | 12.73B | 12.84B | 7.30B | 2.77B | 6.52B | 8.10B |
Balance Sheet | ||||||
| Total Assets | 220.99B | 223.10B | 212.11B | 185.59B | 187.29B | 184.65B |
| Cash, Cash Equivalents and Short-Term Investments | 26.76B | 28.55B | 23.66B | 21.59B | 18.54B | 30.32B |
| Total Debt | 52.66B | 52.75B | 53.14B | 46.06B | 46.21B | 44.16B |
| Total Liabilities | 87.30B | 87.27B | 88.40B | 76.63B | 76.65B | 80.26B |
| Stockholders Equity | 127.97B | 129.73B | 118.19B | 103.79B | 105.82B | 99.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.98B | -1.89B | 470.00M | -10.36B | -6.03B |
| Operating Cash Flow | 0.00 | 19.12B | 5.06B | 7.64B | 6.96B | 7.82B |
| Investing Cash Flow | 0.00 | -11.42B | -7.90B | 1.98B | -17.30B | -1.87B |
| Financing Cash Flow | 0.00 | -3.28B | 4.30B | -7.25B | -1.53B | 1.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥166.86B | 9.78 | 10.24% | 2.43% | 6.08% | 8.55% | |
77 Outperform | ¥794.07B | 3.29 | 27.58% | 0.99% | 9.49% | 55.64% | |
75 Outperform | ¥120.70B | 15.30 | ― | 1.79% | 10.76% | 54.82% | |
72 Outperform | ¥13.66B | 4.54 | ― | 4.80% | 4.49% | 26.84% | |
66 Neutral | ¥136.91B | 17.53 | 2.80% | 3.38% | >-0.01% | -49.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥1.65T | 117.21 | 3.37% | 1.85% | -2.18% | 26.45% |